Matches in SemOpenAlex for { <https://semopenalex.org/work/W2595303003> ?p ?o ?g. }
- W2595303003 endingPage "7" @default.
- W2595303003 startingPage "1" @default.
- W2595303003 abstract "Rett syndrome (RTT) is a neurodevelopmental disorder predominately affecting young females, caused by deficiency of the global transcriptional protein methyl CpG binding protein 2 (MeCP2). Osteoblasts express MeCP2 and girls with RTT experience early onset osteoporosis, decreased bone mass and an increased fracture risk. There is no defined treatment for osteoporosis associated with RTT. The present study evaluated the effects of zoledronic acid (ZA), a third generation nitrogen-containing bisphosphonate with primarily anti-osteoclastic activity, in a mouse model of MeCP2 deficiency. Mice received weekly injections of 20 μg/kg ZA for six weeks. Due to the shortened lifespan of hemizygous male (Mecp2-null) mice, treatment began at 3 weeks of age for this group and corresponding wildtype (WT) male mice. Treatment for heterozygous (HET) and WT female mice began at 8 weeks of age. Micro-computed tomography (micro-CT) and dynamic analyses of bone turnover were performed. ZA treatment led to significant increases in bone volume fraction, number, connectivity density and apparent density of trabecular bone in all genotypes of mice. In contrast, cortical bone generally was unaffected by ZA injections. Parameters of bone turnover, including mineral apposition rate, labeled bone surface and bone formation rate decreased after treatment with ZA. Mecp2-null mice had reduced labeled bone surface and bone formation rate compared to WT male mice. The results indicate that ZA treatment significantly improved trabecular bone mass in a murine model of RTT with little effect on cortical bone." @default.
- W2595303003 created "2017-03-23" @default.
- W2595303003 creator A5052937680 @default.
- W2595303003 creator A5072170168 @default.
- W2595303003 creator A5083825372 @default.
- W2595303003 creator A5087413391 @default.
- W2595303003 creator A5090853715 @default.
- W2595303003 date "2017-06-01" @default.
- W2595303003 modified "2023-09-23" @default.
- W2595303003 title "Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome" @default.
- W2595303003 cites W1559742681 @default.
- W2595303003 cites W1965154023 @default.
- W2595303003 cites W1971897382 @default.
- W2595303003 cites W1973179228 @default.
- W2595303003 cites W1985334727 @default.
- W2595303003 cites W1997579601 @default.
- W2595303003 cites W1998836442 @default.
- W2595303003 cites W2000132672 @default.
- W2595303003 cites W2000211715 @default.
- W2595303003 cites W2007569697 @default.
- W2595303003 cites W2014364856 @default.
- W2595303003 cites W2015963210 @default.
- W2595303003 cites W2019076654 @default.
- W2595303003 cites W2039276157 @default.
- W2595303003 cites W2047018489 @default.
- W2595303003 cites W2052465119 @default.
- W2595303003 cites W2060477169 @default.
- W2595303003 cites W2066749771 @default.
- W2595303003 cites W2074260612 @default.
- W2595303003 cites W2078761085 @default.
- W2595303003 cites W2078888308 @default.
- W2595303003 cites W2083091684 @default.
- W2595303003 cites W2084865918 @default.
- W2595303003 cites W2086801876 @default.
- W2595303003 cites W2090477102 @default.
- W2595303003 cites W2090967864 @default.
- W2595303003 cites W2096425957 @default.
- W2595303003 cites W2098133839 @default.
- W2595303003 cites W2112481119 @default.
- W2595303003 cites W2116206126 @default.
- W2595303003 cites W2127311839 @default.
- W2595303003 cites W2131284079 @default.
- W2595303003 cites W2152668149 @default.
- W2595303003 cites W2154057943 @default.
- W2595303003 cites W2158160219 @default.
- W2595303003 cites W2166972019 @default.
- W2595303003 cites W2261933367 @default.
- W2595303003 cites W2297147396 @default.
- W2595303003 cites W2331878351 @default.
- W2595303003 cites W2335940865 @default.
- W2595303003 cites W4244471308 @default.
- W2595303003 cites W778301592 @default.
- W2595303003 doi "https://doi.org/10.1016/j.bone.2017.03.040" @default.
- W2595303003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28323142" @default.
- W2595303003 hasPublicationYear "2017" @default.
- W2595303003 type Work @default.
- W2595303003 sameAs 2595303003 @default.
- W2595303003 citedByCount "7" @default.
- W2595303003 countsByYear W25953030032017 @default.
- W2595303003 countsByYear W25953030032020 @default.
- W2595303003 countsByYear W25953030032021 @default.
- W2595303003 countsByYear W25953030032022 @default.
- W2595303003 countsByYear W25953030032023 @default.
- W2595303003 crossrefType "journal-article" @default.
- W2595303003 hasAuthorship W2595303003A5052937680 @default.
- W2595303003 hasAuthorship W2595303003A5072170168 @default.
- W2595303003 hasAuthorship W2595303003A5083825372 @default.
- W2595303003 hasAuthorship W2595303003A5087413391 @default.
- W2595303003 hasAuthorship W2595303003A5090853715 @default.
- W2595303003 hasConcept C104317684 @default.
- W2595303003 hasConcept C117866178 @default.
- W2595303003 hasConcept C126322002 @default.
- W2595303003 hasConcept C127716648 @default.
- W2595303003 hasConcept C134018914 @default.
- W2595303003 hasConcept C142724271 @default.
- W2595303003 hasConcept C170033053 @default.
- W2595303003 hasConcept C185592680 @default.
- W2595303003 hasConcept C2776326535 @default.
- W2595303003 hasConcept C2776541429 @default.
- W2595303003 hasConcept C2776886416 @default.
- W2595303003 hasConcept C2777251235 @default.
- W2595303003 hasConcept C2777543196 @default.
- W2595303003 hasConcept C2778863441 @default.
- W2595303003 hasConcept C2781451080 @default.
- W2595303003 hasConcept C55493867 @default.
- W2595303003 hasConcept C71924100 @default.
- W2595303003 hasConceptScore W2595303003C104317684 @default.
- W2595303003 hasConceptScore W2595303003C117866178 @default.
- W2595303003 hasConceptScore W2595303003C126322002 @default.
- W2595303003 hasConceptScore W2595303003C127716648 @default.
- W2595303003 hasConceptScore W2595303003C134018914 @default.
- W2595303003 hasConceptScore W2595303003C142724271 @default.
- W2595303003 hasConceptScore W2595303003C170033053 @default.
- W2595303003 hasConceptScore W2595303003C185592680 @default.
- W2595303003 hasConceptScore W2595303003C2776326535 @default.
- W2595303003 hasConceptScore W2595303003C2776541429 @default.
- W2595303003 hasConceptScore W2595303003C2776886416 @default.
- W2595303003 hasConceptScore W2595303003C2777251235 @default.